Showing results (811-820 of 4,096) with videos related to

Sort By:
Pageof 410
Endocrine Journal|June 29, 2016
Relationship between metabolic syndrome and metabolic syndrome score and beta cell function by gender in Korean populations with obesityHyun Yoon, Dae Keun Jeong, Kyu Su Lee, et al.
Endocrine Journal|December 4, 2015
Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review]Yasuhiro Ito, Hitomi Oda, Akira Miyauchi
Endocrine Journal|December 4, 2015
Serum free thyroxine levels are associated with the efficacy of weight reduction therapy in obese female patientsKoshi Hashimoto, Tetsuya Tagami, Hajime Yamakage, et al.
Endocrine Journal|August 1, 2015
Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterizationJin-Fang Ge, Ya-Yun Xu, Ning Li, et al.
Endocrine Journal|August 30, 2014
Low-dose glimepiride with sitagliptin improves glycemic control without dose-dependency in patients with type 2 diabetes inadequately controlled on high-dose glimepirideRieko Umayahara, Takako Yonemoto, Chika Kyou, et al.
Endocrine Journal|September 3, 2015
Association of periodontitis with insulin resistance, β-cell function, and impaired fasting glucose before onset of diabetesS K M Azizul Islam, Minchul Seo, Young-Sil Lee, et al.
Endocrine Journal|October 20, 2015
Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing's disease: A single-center studyShozo Yamada, Naoko Inoshita, Noriaki Fukuhara, et al.
Endocrine Journal|October 20, 2015
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trialMasanori Emoto, Yasuo Terauchi, Akichika Ozeki, et al.
Endocrine Journal|October 23, 2015
Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, JapanYukiko Tabuchi, Michio Otsuki, Soji Kasayama, et al.
Endocrine Journal|October 21, 2014
Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozinMitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-aki Matsuoka, et al.
Pageof 410